On December 20, the US FDA approved the use of injectable PrEP, which is great news for those at risk of HIV infection. Because the prevention method does not require taking pills every day, but rather requires injections at the clinic every 2 months after the first 2 injections are 1 month apart. This will help some people who cannot or are not comfortable taking pills every day. Because if you miss a dose, the effectiveness of prevention will be reduced, which creates additional risks. From the experiment, Apretude is effective in reducing the risk of HIV infection by more than 69% when compared to the oral PrEP Travuda. As for when the Thai FDA will approve it, there is no date yet, but you can wait. It will be a good option for HIV prevention.
For those who are interested in receiving PrEP, you can book at >> testBKK.org/website
